Navigation Links
Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014
Date:11/26/2014

RADNOR, Pa., Nov. 26, 2014 /PRNewswire/ -- Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the company will present at the Piper Jaffray 26th Annual Healthcare Conference 2014. The conference will be held December 2 to 3, 2014,at the New York Palace in New York. Zynerba's Chairman and CEO, Armando Anido, will present at 4:50 pm on Tuesday, December 2.

To listen to a webcast of this presentation during the event, please visit the Investor Relations page of www.zynerba.com.

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical needs using modern drug delivery technology and appropriate regulatory pathways. Zynerba is developing two therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of cannabinoids. Transdermal delivery reduces adverse effects associated with oral dosing. ZYN001 will be studied in chronic cancer pain, fibromyalgia, and peripheral neuropathic pain utilizing a synthetically manufactured prodrug of THC in a transdermal patch to deliver THC through the skin and into the bloodstream. Zynerba expects to initiate ZYN001 Phase 1 clinical studies in 3Q 2015. ZYN002 will be studied in refractory epilepsy and arthritis, utilizing a proprietary gel to deliver synthetically manufactured cannabidiol (CBD), a non-psychotropic cannabinoid, through the skin and into the bloodstream. Zynerba expects to initiate ZYN002 Phase 1 clinical studies in 3Q 2015. Learn more at www.zynerba.com and follow the company on Twitter at @ZynerbaPharma.


'/>"/>
SOURCE Zynerba Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Zynerba Pharmaceuticals Raises $13 Million to Develop First and Only Transdermal Cannabinoid Therapies
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2018)... ... ... Dr. Rod J. Rohrich is pleased to announce that registration is now open ... around the world, will take place from March 22nd and 23rd, 2019. The annual ... complex surgical procedures and detailed analysis of revision rhinoplasty . Formats include lectures, ...
(Date:9/13/2018)... ... September 13, 2018 , ... AccentCare, ... August 31, 2018, making its regional Texas Home Health operations the largest ... home health, hospice, and personal care services. , Texas Home Health operations serve ...
(Date:9/13/2018)... ... September 13, 2018 , ... ... know | 2018" list. , Hospitals and health systems rely on CIOs and ... well as support telehealth, data-gathering and cybersecurity initiatives. Those who lead community hospital ...
Breaking Medicine Technology:
(Date:9/13/2018)... ... ... The Kelly Foundation awarded $83,000 to Saint John’s Program for Reach ... homelessness in the Sacramento region. The donation will go towards the Bridge the ... open after the County of Sacramento decided not to renew its 15-year contract. The ...
(Date:9/12/2018)... ... September 12, 2018 , ... Definitive Healthcare , the leading ... annual golf tournament supporting the Dana-Farber Cancer Institute and the Jimmy Fund. , ... the tournament director. “I’m happy we have such wonderful sponsors and volunteers. The growth ...
(Date:9/7/2018)... ... September 07, 2018 , ... Start your engines and race ... sports experiences from which to choose. Pedal power is the name of the game ... Experience or turning left on the miniature Indianapolis Motor Speedway oval. , The timing ...
(Date:9/2/2018)... ... September 01, 2018 , ... ... proud to add HydraFacial MD® Elite to its leading menu of results-driven ... vortex-suction technology and an infusion of clinically-proven ingredients to dramatically improve your ...
(Date:9/1/2018)... ... August 31, 2018 , ... Alice Branton shared her personal story on ... with Daytime host Jerry Penacoli. , With all the medical advancements over the ... is a major public health problem worldwide irrespective of age, location, ethnicity, and gender. ...
Breaking Medicine News(10 mins):